Orbis Medicines AG
Biotechnology · Epalinges, Vaud
Orbis Medicines AG is a Swiss biotechnology company based in Epalinges, Canton of Vaud, listed in the Swiss commercial register since 2022 (UID CHE-211.311.563).
Board members & signatories
- Nielsen Simon — Direktor
- Brodbeck Daniela
Registered purpose
la Société a pour objet la recherche dans le secteur des sciences de la vie et la fourniture de services connexes. La Société peut en outre: détenir des participations dans le secteur des sciences de la vie; acquérir, détenir, grever et vendre des droits de propriété intellectuelle; conclure toutes opérations commerciales, contractuelles et financières incluant la location et le transfert (achat e…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What Orbis Medicines does
OFFERING
Orbis Medicines AG focuses on the discovery and development of oral macrocycle drugs through its nGen platform. This platform enables the systematic exploration of macrocycle chemical space, producing drug candidates optimized for oral bioavailability and membrane permeability. Their pipeline includes oral macrocycle candidates targeting validated biologic drug targets, with an emphasis on both intra- and extracellular therapeutic areas.
Unlock the full analysis →Similar companies
- ADC Therapeutics AG — Biotechnology · Epalinges
- AC Immune AG — Biotechnology · Lausanne
- ReproNovo SA — Biotechnology · Lausanne
- Limula AG — Biotechnology · La Tour-de-Peilz
- Nagi Bioscience AG — Biotechnology · St-Sulpice VD
- ND BioSciences SA — Biotechnology · Epalinges
Find every biotechnology company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned biotechnology companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime